GRCE
Bank of America’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Hold |
494,698
| – | – | ﹤0.01% | 4210 |
|
|
2025
Q1 | $1.13M | Hold |
494,698
| – | – | ﹤0.01% | 4290 |
|
|
2024
Q4 | $1.85M | Hold |
494,698
| – | – | ﹤0.01% | 3805 |
|
|
2024
Q3 | $1.48M | Hold |
494,698
| – | – | ﹤0.01% | 4045 |
|
|
2024
Q2 | $1.44M | Hold |
494,698
| – | – | ﹤0.01% | 3968 |
|
|
2024
Q1 | $1.69M | Hold |
494,698
| – | – | ﹤0.01% | 3826 |
|
|
2023
Q4 | $1.43M | Hold |
494,698
| – | – | ﹤0.01% | 3882 |
|
|
2023
Q3 | $1.38M | Buy |
+494,698
| New | +$1.38M | ﹤0.01% | 3810 |
|
|
2022
Q2 | – | Sell |
-56,583
| Closed | -$69K | – | 7455 |
|
|
2022
Q1 | $69K | Buy |
56,583
+35,962
| +174% | +$43.9K | ﹤0.01% | 6246 |
|
|
2021
Q4 | $26K | Buy |
20,621
+19,996
| +3,199% | +$25.2K | ﹤0.01% | 6577 |
|
|
2021
Q3 | $1K | Sell |
625
-1,875
| -75% | -$3K | ﹤0.01% | 7108 |
|
|
2021
Q2 | $1K | Hold |
2,500
| – | – | ﹤0.01% | 6833 |
|
|
2021
Q1 | $2K | Hold |
2,500
| – | – | ﹤0.01% | 6545 |
|
|
2020
Q4 | $1K | Sell |
2,500
-2,000
| -44% | -$800 | ﹤0.01% | 6239 |
|
|
2020
Q3 | $1K | Hold |
4,500
| – | – | ﹤0.01% | 6124 |
|
|
2020
Q2 | $2K | Hold |
4,500
| – | – | ﹤0.01% | 6068 |
|
|
2020
Q1 | $2K | Sell |
4,500
-76,824
| -94% | -$34.1K | ﹤0.01% | 6025 |
|
|
2019
Q4 | $199K | Buy |
81,324
+77,179
| +1,862% | +$189K | ﹤0.01% | 4860 |
|
|
2019
Q3 | $8K | Buy |
+4,145
| New | +$8K | ﹤0.01% | 5918 |
|
|
2019
Q1 | – | Sell |
-37,771
| Closed | -$31K | – | 6497 |
|
|
2018
Q4 | $31K | Buy |
+37,771
| New | +$31K | ﹤0.01% | 5605 |
|
|
2014
Q1 | – | Sell |
-275
| Closed | – | – | 6050 |
|
|
2013
Q4 | $0 | Buy |
+275
| New | – | ﹤0.01% | 6155 |
|